Prognostic Value of the Expression of Tumor Suppressor Genes p53, p21, p16 and pRb, and Ki-67 Labelling in High Grade Astrocytomas Treated with Radiotherapy

Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

Giorgio Cattoretti, Michael H. G. Becker, Göran Key et al. · The Journal of Pathology · 1992 · 1.5K citations

Life Sciences, Cell Biology, Pathology +14

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Johannes Gerdes, Lingjun Li, Carol J. Schlueter et al. · PubMed · 1991 · 899 citations

Medicine, Oncology, Pathology +16

Overexpression of the EGF Receptor and <i>p53</i> Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas

Kunihiko Watanabe, Osamu Tachibana, Kazufumi Sato et al. · Brain Pathology · 1996 · 734 citations · Full text

Medicine, Genetics, Oncology +17

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma

NM Bleehen, SP Stenning · British Journal of Cancer · 1991 · 413 citations · Full text

Medicine, Oncology, Radiation Oncology +14

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

Keisuke Ueki, Yasuhiro Ono, John W. Henson et al. · PubMed · 1996 · 408 citations

Medicine, Genetics, Oncology +17